Vivani Medical
Price & Volume
Stats
See moreOpen | $1.26 |
Previous Close | $1.27 |
Day Range | $1.24-$1.27 |
52W Range | $0.90-$1.80 |
Market Cap | $74.6M |
Shares Short | 368,331 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $130,000 |
Diluted EPS | -$0.42 |
News
See moreYahoo Finance • 2 days ago
Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results
Yahoo Finance • 11 days ago
Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 Phase 1 Clinical Study of NPM-115
Yahoo Finance • 11 days ago
EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data
About
CEO | Dr. Adam Mendelsohn Ph.D. |
Address | 1350 South Loop Road, Alameda, CA, United States, 94502 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 37 |
